At a glance
ClinicalIndex Comparison RecordN/ACompleted· 37 enrolled
Drug / intervention
Cardiac Ablation for the treatment of persistent Atrial Fibrillationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm
In Brief
An observational study evaluating Cardiac Ablation for the treatment of persistent Atrial Fibrillation for Persistent Atrial Fibrillation and Cardiac Arrhythmia. Completed, enrolled 37 participants across 1 site.
Detailed Summary
To acquire, amplify, digitize, and record atrial intracardiac electrophysiology signals during cardiac electrophysiology studies for the treatment of persistent atrial fibrillation and to use the recorded data to test the performance of an signal complexity visualization algorithm.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPersistent Atrial Fibrillation, Cardiac Arrhythmia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJul 2022
Enrollment StartJul 2022
Primary CompletionOct 2023
Study CompletionDec 2024
TodayJul 2026
First PostedJul 14, 2022
Enrollment StartJul 28, 2022
Primary CompletionOct 30, 2023
Study CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.0 years ago
Interventions
Cardiac Ablation for the treatment of persistent Atrial Fibrillationprocedure
Patients participating in the study will undergo a cardiac ablation for the treatment of persistent atrial fibrillation.